Organigram’s Promising Results From Nanoemulsion Technology Study To Improve Cannabis Edibles
Toronto-based, Organigram Holdings Inc. (NASDAQ:OGI) announced promising preliminary results from a landmark clinical study on their new nanoemulsion technology. This innovation, branded FAST (Fast Acting Soluble Technology) aims to innovate the company’s edibles products. The study, part of the Product Development Collaboration (PDC), highlights the potential benefits of this nanoemulsion technology, which has recently been explored in the cannabis industry.
Key Findings
According to the company, the clinical study – completed in January 2024 – has shown significant advances. Organigram has been a long time explorer of these types of developments. In this case, the technology demonstrated a faster onset of effects, up to 50% quicker compared to traditional ingestible products. Additionally, the study found improved bioavailability, with up to double the …